Viking Therapeutics (VKTX) Earnings Date, Estimates & Call Transcripts $30.19 +2.68 (+9.74%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$30.35 +0.16 (+0.52%) As of 07/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Viking Therapeutics Earnings Summary Viking Therapeutics posted Q1 2025 earnings on April 23, 2025, reporting an EPS of -$0.41, which missed analysts' consensus estimates of -$0.31 by $0.10. Its revenue for the quarter was up .0% compared to the same quarter last year. With a trailing EPS of -$1.15, Viking Therapeutics' earnings are expected to decrease next year, from ($1.56) to ($2.07) per share. Upcoming Q2 Earnings DateJul. 23After Market ClosesEstimatedConsensus EPS (Apr. 23) -$0.31 Actual EPS (Apr. 23) -$0.41 Missed By -$0.10 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)VKTX Upcoming EarningsViking Therapeutics' Q2 2025 earnings is scheduled for Wednesday, July 23, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get Viking Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Viking Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVKTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Viking Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$0.35-$0.26-$0.31Q2 20254-$0.45-$0.42-$0.44Q3 20254-$0.49-$0.45-$0.47Q4 20254-$0.52-$0.47-$0.49 FY 2025 16 -$1.81 -$1.60 -$1.70 Q1 20261-$0.54-$0.54-$0.54Q2 20261-$0.55-$0.55-$0.55Q3 20261-$0.56-$0.56-$0.56Q4 20261-$0.57-$0.57-$0.57 Viking Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/23/2025(Estimated)-------4/23/2025Q1 2025-$0.31-$0.41 -$0.10-$0.41--2/5/2025Q4 2024-$0.27-$0.32 -$0.05-$0.32--10/23/2024Q3 2024-$0.24-$0.22+$0.02-$0.22--7/24/2024Q2 2024-$0.26-$0.20+$0.06-$0.20--4/24/2024Q1 2024-$0.27-$0.26+$0.01-$0.26--2/7/2024Q4 2023-$0.25-$0.25--$0.25--10/25/2023Q3 2023-$0.22-$0.23 -$0.01-$0.23--7/26/2023Q2 2023-$0.21-$0.19+$0.02-$0.19-- Viking Therapeutics Earnings - Frequently Asked Questions When is Viking Therapeutics' earnings date? Viking Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 23rd, 2025 based off last year's report dates. Learn more on VKTX's earnings history. Did Viking Therapeutics beat their earnings estimates last quarter? In the previous quarter, Viking Therapeutics (NASDAQ:VKTX) missed the analysts' consensus estimate of ($0.31) by $0.10 with a reported earnings per share (EPS) of ($0.41). Learn more on analysts' earnings estimate vs. VKTX's actual earnings. How can I listen to Viking Therapeutics' earnings conference call? The conference call for Viking Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Viking Therapeutics' conference call transcript? The conference call transcript for Viking Therapeutics' latest earnings report can be read online. Read Transcript How much profit does Viking Therapeutics generate each year? Viking Therapeutics (NASDAQ:VKTX) has a recorded net income of -$109.96 million. VKTX has generated -$1.15 earnings per share over the last four quarters. What is Viking Therapeutics' EPS forecast for next year? Viking Therapeutics' earnings are expected to decrease from ($1.56) per share to ($2.07) per share in the next year. More Earnings Resources from MarketBeat Related Companies Madrigal Pharmaceuticals Earnings Results Eli Lilly and Company Earnings Results Moderna Earnings Results Viatris Earnings Results Ascendis Pharma A/S Earnings Results QIAGEN Earnings Results Blueprint Medicines Earnings Results BridgeBio Pharma Earnings Results Verona Pharma PLC American Depositary Share Earnings Results Roivant Sciences Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:VKTX) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
